Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1902685 | 1.00 | THRB (0.32) | THRBMEN1KMT2A | |
| SCHEMBL1906309 | 1.00 | THRB (0.32) | THRBMEN1KMT2A | |
| SCHEMBL1904188 | 1.00 | THRB (0.32) | THRBMEN1KMT2A | |
| SCHEMBL1906308 | 1.00 | THRB (0.32) | THRBMEN1KMT2A | |
| SCHEMBL1902688 | 1.00 | THRB (0.32) | THRBMEN1KMT2A | |
| SCHEMBL3630201 | 1.00 | THRB (0.32) | THRBMEN1KMT2A | |
| SCHEMBL12605612 | 1.00 | THRB (0.32) | THRBMEN1KMT2A | |
| SCHEMBL1904888 | 0.97 | THRB (0.30) | THRBMEN1KMT2A | |
| SCHEMBL1900891 | 0.97 | THRB (0.30) | THRBMEN1KMT2A | |
| SCHEMBL1902819 | 0.97 | THRB (0.30) | THRBMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140221475-A1 | PLATINUM(IV) COMPLEXES AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | UNITECH CO., LTD. (JP) | 2014-08-07 | — | — | US | claimed |
| EP-2743252-A1 | TETRAVALENT PLATINUM COMPLEX AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | Unitech Co., Ltd (JP) | 2014-06-18 | — | — | EP | claimed |
| US-20140221475-A1 | PLATINUM(IV) COMPLEXES AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | UNITECH CO., LTD. (JP) | 2014-08-07 | — | — | US | disclosed |
| EP-2743252-A1 | TETRAVALENT PLATINUM COMPLEX AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | Unitech Co., Ltd (JP) | 2014-06-18 | — | — | EP | disclosed |
| US-8501977-B2 | Platinum complex and pharmaceutical composition containing the same | UNITECH CO., LTD. (JP) | 2013-08-06 | — | — | US | disclosed |
| US-8039675-B2 | Catalysts | JOHNSON MATTHEY PLC (GB) | 2011-10-18 | — | — | US | disclosed |
| US-20110152555-A1 | PLATINUM COMPLEX AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | UNITECH CO., LTD. (JP) | 2011-06-23 | — | — | US | disclosed |
| EP-2325163-A1 | PLATINUM COMPLEX AND MEDICAL COMPOUND CONTAINING SAME | Unitech Co., Ltd (JP) | 2011-05-25 | — | — | EP | disclosed |
| US-20100197976-A1 | CATALYSTS | JOHNSON MATTHEY PLC (GB) | 2010-08-05 | — | — | US | disclosed |
| US-20070066850-A1 | Catalysts | JOHNSON MATTHEY PLC (GB) | 2007-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070066850-A1 | Catalysts | HRH3, PRMT1, HRH4 | THRB 3535/4885MEN1 694/4885KMT2A 1111/4885 |
| US-20110152555-A1 | PLATINUM COMPLEX AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | PKD1, XPA, CCDC47 | THRB 2149/4885MEN1 194/4885KMT2A 2990/4885 |
| US-20140221475-A1 | PLATINUM(IV) COMPLEXES AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | PKD1, DLD, PAICS | THRB 1098/4885MEN1 475/4885KMT2A 2780/4885 |
| US-20100197976-A1 | CATALYSTS | HRH3, HRH2, PRMT8 | THRB 3614/4885MEN1 675/4885KMT2A 1102/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.